They have been shown to be involved in tumor progression by inhibiting the activity of CD4+ and CD8+ T cells, by the production of arginase and reactive oxygen species (ROS) and by inducing Tregs through an IL-10 and IFN-γ-dependent process. This evidence concerns the gene CD4 and neoplasm.